3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
56
Phase 3
34
Phase 1
8
Phase 2/3
7
Phase 1/2
4
Phase NA
2
Phase 4
1
Status
Completed
2
Sponsor Class
OTHER
33
NIH
3
NETWORK
2
UNKNOWN
1
OTHER_GOV
1
FED
1
Study Type
Interventional
2
Sponsor
Cancer Type
Head & Neck
1
Breast
1
Conditions
Head and Neck Neoplasms
1
Breast Neoplasms, Male
1
Breast Neoplasms
1
Interventions
Radiotherapy
10
Early Intervention, Educational
7
Standard of Care
6
Magnetic Resonance Spectroscopy
6
Interviews as Topic
6
Educational Status
6
Radiotherapy, Conformal
5
Practice Guidelines as Topic
5
Methods
5
Cyclophosphamide
5
Vincristine
4
Psychiatric Rehabilitation
4
Cisplatin
4
Brachytherapy
4
Biopsy
4
Surgical Procedures, Operative
3
Specimen Handling
3
Radiosurgery
3
Granulocyte Colony-Stimulating Factor
3
Filgrastim
3
Etoposide
3
Dexamethasone
3
Counseling
3
Carboplatin
3
pegaspargase
2
motexafin gadolinium
2
etoposide phosphate
2
Radiofrequency Ablation
2
Radiation
2
Preoperative Exercise
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase NA
×
NETWORK
×
Docetaxel
×
Clear all
NCT00502463
2024-02-07
ASOG-HNO1
Austrian South Oncology Group
Phase NA
Completed
51 enrolled
NCT00911716
2019-08-01
TC Avastin. ICORG 08-10, V6
Cancer Trials Ireland
Phase NA
Completed
106 enrolled